Cardinal Health™ Sonexus™ Access And Patient Support For Cell And Gene Therapy

While the scientific advancements of cell and gene therapies (CGTs) garner significant attention, it is crucial to recognize that the success of any precision medicine ultimately hinges on patient experience. Personalization of the therapy itself is paramount, but ensuring a personalized treatment journey is equally significant.

Numerous financial and logistical obstacles can impede patient access to these potentially transformative treatments. As manufacturers prepare for CGT commercialization, a deep understanding of the complex patient navigation pathway is crucial. Neglecting this critical aspect can jeopardize even the most meticulously planned product launch.

Therefore, a robust patient support strategy designed to navigate the entire treatment journey becomes non-negotiable. This is where experienced patient support hubs can play a pivotal role, significantly reducing the time between treatment determination and therapy initiation for CGT patients.

Developing effective patient support programs necessitates a multifaceted approach considering various factors, which will be explored in detail below.